See also this year's filing and all EDGAR filings for this company.
PDF Report 0001175505_2017_FIVE_Prime_Therapeutics_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001175505, FIVE Prime Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 440,125,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,207,000 |
| 3 | remainder_Assets | 1,949,000 |
| 4 | LiabilitiesCurrent | 38,741,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 35,831,000 |
| 9 | ResearchAndDevelopmentExpense | 94,072,000 |
| 10 | remainder_Expenses | -31,048,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 33,158,000 |
| 13 | remainder_ComprehensiveNetIncome | 35,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 448,281,000 |
| 1 | Liabilities | 38,741,000 |
| 2 | Expenses | 98,855,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 409,540,000 |
| 5 | NetIncome | -65,697,000 |
| 6 | ComprehensiveNetIncome | -65,679,500 |
| 7 | BaseVar | 309,535,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.40 |
| 9 | EconomicCapitalRatio | 3.96 |
Edgar->Model Mapping
Feature Distribution
